{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:27:35Z","timestamp":1794317255890,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["13647"],"award-info":[{"award-number":["13647"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["15986"],"award-info":[{"award-number":["15986"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["ERC-2023-ADG-101141245"],"award-info":[{"award-number":["ERC-2023-ADG-101141245"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41556-026-02088-3","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:02:07Z","timestamp":1791190927000},"page":"2291-2304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global and specific mechanisms stimulate mistranslation in cancer"],"prefix":"10.1038","volume":"28","author":[{"given":"Demi","family":"Wernaart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6726-1752","authenticated-orcid":false,"given":"Amos","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrittika","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-1932","authenticated-orcid":false,"given":"Xiaodong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4543-8455","authenticated-orcid":false,"given":"Olaf","family":"Geintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin S.","family":"Kyei-Baffour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9395-2347","authenticated-orcid":false,"given":"Onno B.","family":"Bleijerveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3552-6390","authenticated-orcid":false,"given":"Liesbeth","family":"Hoekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceri","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne","family":"Giebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Burylo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Proost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Ren\u00e9","family":"K\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Anna","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6172-5422","authenticated-orcid":false,"given":"Eric","family":"Westhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-858X","authenticated-orcid":false,"given":"Julien","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1037-6269","authenticated-orcid":false,"given":"Olaf","family":"van Tellingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Rodnina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-2473","authenticated-orcid":false,"given":"Reuven","family":"Agami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"2088_CR1","doi-asserted-by":"publisher","first-page":"e44235","DOI":"10.7554\/eLife.44235","volume":"8","author":"MR Sullivan","year":"2019","unstructured":"Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. eLife 8, e44235 (2019).","journal-title":"eLife"},{"key":"2088_CR2","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers, M. et al. IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J. Clin. Invest. 127, 2930\u20132940 (2017).","journal-title":"J. Clin. Invest."},{"key":"2088_CR3","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-15-0420","volume":"21","author":"L Zhai","year":"2015","unstructured":"Zhai, L. et al. Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy. Clin. Cancer Res. 21, 5427\u20135433 (2015).","journal-title":"Clin. Cancer Res."},{"key":"2088_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-319-67577-0_9","volume":"1036","author":"A Amobi","year":"2017","unstructured":"Amobi, A., Qian, F., Lugade, A. A. & Odunsi, K. Tryptophan catabolism and cancer immunotherapy targeting IDO mediated immune suppression. Adv. Exp. Med. Biol. 1036, 129\u2013144 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2088_CR5","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/1078-0432.CCR-18-2882","volume":"25","author":"BW Labadie","year":"2019","unstructured":"Labadie, B. W., Bao, R. & Luke, J. J. Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan-kynurenine-aryl hydrocarbon axis. Clin. Cancer Res. 25, 1462\u20131471 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2088_CR6","first-page":"7007","volume":"44","author":"JF Atkins","year":"2016","unstructured":"Atkins, J. F., Loughran, G., Bhatt, P. R., Firth, A. E. & Baranov, P. V. Ribosomal frameshifting and transcriptional slippage: from genetic steganography and cryptography to adventitious use. Nucleic Acids Res. 44, 7007\u20137078 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2088_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fgene.2012.00242","volume":"3","author":"R Ketteler","year":"2012","unstructured":"Ketteler, R. On programmed ribosomal frameshifting: the alternative proteomes. Front. Genet. 3, 242 (2012).","journal-title":"Front. Genet."},{"key":"2088_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.tig.2022.05.009","volume":"38","author":"J Champagne","year":"2022","unstructured":"Champagne, J., Mordente, K., Nagel, R. & Agami, R. Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting. Trends Genet. 38, 1123\u20131133 (2022).","journal-title":"Trends Genet."},{"key":"2088_CR9","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1016\/j.molcel.2021.09.002","volume":"81","author":"J Champagne","year":"2021","unstructured":"Champagne, J. et al. Oncogene-dependent sloppiness in mRNA translation. Mol. Cell 81, 4709\u20134721.e4709 (2021).","journal-title":"Mol. Cell"},{"key":"2088_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","volume":"590","author":"O Bartok","year":"2021","unstructured":"Bartok, O. et al. Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature 590, 332\u2013337 (2021).","journal-title":"Nature"},{"key":"2088_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41586-022-04499-2","volume":"603","author":"A Pataskar","year":"2022","unstructured":"Pataskar, A. et al. Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature 603, 721\u2013727 (2022).","journal-title":"Nature"},{"key":"2088_CR12","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/s41388-024-03069-2","volume":"43","author":"D Wernaart","year":"2024","unstructured":"Wernaart, D., Fumagalli, A. & Agami, R. Molecular mechanisms of non-genetic aberrant peptide production in cancer. Oncogene 43, 2053\u20132062 (2024).","journal-title":"Oncogene"},{"key":"2088_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.immuni.2024.12.004","volume":"58","author":"J Champagne","year":"2025","unstructured":"Champagne, J. et al. Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation. Immunity 58, 247\u2013262.e249 (2025).","journal-title":"Immunity"},{"key":"2088_CR14","doi-asserted-by":"publisher","first-page":"13964","DOI":"10.1093\/nar\/gkae1110","volume":"52","author":"A Kochavi","year":"2024","unstructured":"Kochavi, A. et al. Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer. Nucleic Acids Res. 52, 13964\u201313979 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2088_CR15","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.molcel.2024.04.012","volume":"84","author":"C Yang","year":"2024","unstructured":"Yang, C. et al. Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants. Mol. Cell 84, 1904\u20131916.e1907 (2024).","journal-title":"Mol. Cell"},{"key":"2088_CR16","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1158\/0008-5472.CAN-25-4773","volume":"86","author":"R Nagel","year":"2026","unstructured":"Nagel, R. et al. Arginine deprivation of ASS1-deficient cancers drives mistranslation and shared neoepitope production. Cancer Res. 86, 3480\u20133501 (2026).","journal-title":"Cancer Res."},{"key":"2088_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-1-4939-9450-2_9","volume":"1988","author":"D Dersh","year":"2019","unstructured":"Dersh, D., Yewdell, J. W. & Wei, J. A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics. Methods Mol. Biol. 1988, 109\u2013122 (2019).","journal-title":"Methods Mol. Biol."},{"key":"2088_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41420-025-02698-0","volume":"11","author":"Z Zou","year":"2025","unstructured":"Zou, Z. et al. Current landscape of the immunoproteasome: implications for disease and therapy. Cell Death Discov. 11, 406 (2025).","journal-title":"Cell Death Discov."},{"key":"2088_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w","volume":"8","author":"M Sade-Feldman","year":"2017","unstructured":"Sade-Feldman, M. et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat. Commun. 8, 1136 (2017).","journal-title":"Nat. Commun."},{"key":"2088_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"2088_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol"},{"key":"2088_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/jnci\/djt184","volume":"105","author":"P Leone","year":"2013","unstructured":"Leone, P. et al. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. J. Natl Cancer Inst. 105, 1172\u20131187 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"2088_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0960-9822(98)70130-7","volume":"8","author":"GJ Arts","year":"1998","unstructured":"Arts, G. J., Fornerod, M. & Mattaj, I. W. Identification of a nuclear export receptor for tRNA. Curr. Biol. 8, 305\u2013314 (1998).","journal-title":"Curr. Biol."},{"key":"2088_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.coi.2011.08.009","volume":"23","author":"CK Pfaller","year":"2011","unstructured":"Pfaller, C. K., Li, Z., George, C. X. & Samuel, C. E. Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Curr. Opin. Immunol. 23, 573\u2013582 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"2088_CR25","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.3390\/cancers15215277","volume":"15","author":"V Frezza","year":"2023","unstructured":"Frezza, V., Chellini, L., Del Verme, A. & Paronetto, M. P. RNA editing in cancer progression. Cancers 15, 5277 (2023).","journal-title":"Cancers"},{"key":"2088_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/intimm\/dxac056","volume":"35","author":"T Nakahama","year":"2023","unstructured":"Nakahama, T. & Kawahara, Y. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways. Int. Immunol. 35, 123\u2013133 (2023).","journal-title":"Int. Immunol."},{"key":"2088_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson, K. R. et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 (2018).","journal-title":"Nat. Commun."},{"key":"2088_CR28","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2088_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28841-4","volume":"13","author":"O Gabay","year":"2022","unstructured":"Gabay, O. et al. Landscape of adenosine-to-inosine RNA recoding across human tissues. Nat. Commun. 13, 1184 (2022).","journal-title":"Nat. Commun."},{"key":"2088_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12859-016-1432-8","volume":"18","author":"M Piechotta","year":"2017","unstructured":"Piechotta, M., Wyler, E., Ohler, U., Landthaler, M. & Dieterich, C. JACUSA: site-specific identification of RNA editing events from replicate sequencing data. BMC Bioinform. 18, 7 (2017).","journal-title":"BMC Bioinform."},{"key":"2088_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33260-6","volume":"13","author":"K Niescierowicz","year":"2022","unstructured":"Niescierowicz, K. et al. Adar-mediated A-to-I editing is required for embryonic patterning and innate immune response regulation in zebrafish. Nat. Commun. 13, 5520 (2022).","journal-title":"Nat. Commun."},{"key":"2088_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38581-8","volume":"14","author":"TL Wong","year":"2023","unstructured":"Wong, T. L. et al. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nat. Commun. 14, 2861 (2023).","journal-title":"Nat. Commun."},{"key":"2088_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1073\/pnas.1111561108","volume":"109","author":"J Liu","year":"2012","unstructured":"Liu, J., Xu, Y., Stoleru, D. & Salic, A. Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin. Proc. Natl Acad. Sci. USA. 109, 413\u2013418 (2012).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"2088_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41420-026-03225-5","volume":"12","author":"D Lovecchio","year":"2026","unstructured":"Lovecchio, D. et al. Histidine to glutamine substitutants, a regulated process that impacts cell survival and suggests histidine shortage in cancer. Cell Death Discov. 12, 368 (2026).","journal-title":"Cell Death Discov."},{"key":"2088_CR35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41580-019-0118-2","volume":"20","author":"CAP Joazeiro","year":"2019","unstructured":"Joazeiro, C. A. P. Mechanisms and functions of ribosome-associated protein quality control. Nat. Rev. Mol. Cell Biol. 20, 368\u2013383 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2088_CR36","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1093\/nar\/10.20.6421","volume":"10","author":"Y Kuchino","year":"1982","unstructured":"Kuchino, Y., Borek, E., Grunberger, D., Mushinski, J. F. & Nishimura, S. Changes of post-transcriptional modification of wye base in tumor-specific tRNAPhe. Nucleic Acids Res. 10, 6421\u20136432 (1982).","journal-title":"Nucleic Acids Res."},{"key":"2088_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41587-023-01743-6","volume":"42","author":"MC Lucas","year":"2024","unstructured":"Lucas, M. C. et al. Quantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing. Nat. Biotechnol. 42, 72\u201386 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2088_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcaf044","volume":"7","author":"A Kochavi","year":"2025","unstructured":"Kochavi, A. et al. Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models. NAR Cancer 7, zcaf044 (2025).","journal-title":"NAR Cancer"},{"key":"2088_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15140-z","volume":"11","author":"C Trzaska","year":"2020","unstructured":"Trzaska, C. et al. 2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations. Nat. Commun. 11, 1509 (2020).","journal-title":"Nat. Commun."},{"key":"2088_CR40","doi-asserted-by":"publisher","first-page":"eabf3072","DOI":"10.1126\/sciadv.abf3072","volume":"7","author":"Y Nagayoshi","year":"2021","unstructured":"Nagayoshi, Y. et al. Loss of Ftsj1 perturbs codon-specific translation efficiency in the brain and is associated with X-linked intellectual disability. Sci. Adv. 7, eabf3072 (2021).","journal-title":"Sci. Adv."},{"key":"2088_CR41","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s43018-024-00844-8","volume":"5","author":"LA Nease","year":"2024","unstructured":"Nease, L. A. et al. Selenocysteine tRNA methylation promotes oxidative stress resistance in melanoma metastasis. Nat. Cancer 5, 1868\u20131884 (2024).","journal-title":"Nat. Cancer"},{"key":"2088_CR42","doi-asserted-by":"publisher","first-page":"eadh8502","DOI":"10.1126\/sciadv.adh8502","volume":"9","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. Human SAMD9 is a poxvirus-activatable anticodon nuclease inhibiting codon-specific protein synthesis. Sci. Adv. 9, eadh8502 (2023).","journal-title":"Sci. Adv."},{"key":"2088_CR43","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/humu.22897","volume":"36","author":"MP Guy","year":"2015","unstructured":"Guy, M. P. et al. Defects in tRNA anticodon loop 2\u2019-O-methylation are implicated in nonsyndromic X-linked intellectual disability due to mutations in FTSJ1. Hum. Mutat. 36, 1176\u20131187 (2015).","journal-title":"Hum. Mutat."},{"key":"2088_CR44","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050095","volume":"21","author":"J Li","year":"2020","unstructured":"Li, J. et al. Intellectual disability-associated gene ftsj1 is responsible for 2\u2019-O-methylation of specific tRNAs. EMBO Rep. 21, e50095 (2020).","journal-title":"EMBO Rep."},{"key":"2088_CR45","doi-asserted-by":"publisher","first-page":"e202201877","DOI":"10.26508\/lsa.202201877","volume":"6","author":"M Brazane","year":"2023","unstructured":"Brazane, M. et al. The ribose methylation enzyme FTSJ1 has a conserved role in neuron morphology and learning performance. Life Sci. Alliance 6, e202201877 (2023).","journal-title":"Life Sci. Alliance"},{"key":"2088_CR46","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1158\/0008-5472.CAN-22-1525","volume":"82","author":"R Nagel","year":"2022","unstructured":"Nagel, R., Pataskar, A., Champagne, J. & Agami, R. Boosting antitumor immunity with an expanded neoepitope landscape. Cancer Res. 82, 3637\u20133649 (2022).","journal-title":"Cancer Res."},{"key":"2088_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature07657","volume":"458","author":"D Zehn","year":"2009","unstructured":"Zehn, D., Lee, S. Y. & Bevan, M. J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458, 211\u2013214 (2009).","journal-title":"Nature"},{"key":"2088_CR48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.tig.2022.03.013","volume":"38","author":"AR Baker","year":"2022","unstructured":"Baker, A. R. & Slack, F. J. ADAR1 and its implications in cancer development and treatment. Trends Genet. 38, 821\u2013830 (2022).","journal-title":"Trends Genet."},{"key":"2088_CR49","doi-asserted-by":"publisher","first-page":"116151","DOI":"10.1016\/j.celrep.2025.116151","volume":"44","author":"\u00c1 \u00c1lvarez-Prado","year":"2025","unstructured":"\u00c1lvarez-Prado, \u00c1 et al. Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival. Cell Rep. 44, 116151 (2025).","journal-title":"Cell Rep."},{"key":"2088_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2525-x","volume":"11","author":"Q He","year":"2020","unstructured":"He, Q. et al. FTSJ1 regulates tRNA 2\u2019-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression. Cell Death Dis. 11, 348 (2020).","journal-title":"Cell Death Dis."},{"key":"2088_CR51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/cancers16030597","volume":"16","author":"Y Sun","year":"2024","unstructured":"Sun, Y., Liu, Q., Zhong, S., Wei, R. & Luo, J. L. Triple-negative breast cancer intrinsic FTSJ1 favors tumor progression and attenuates CD8+ T cell infiltration. Cancers 16, 597 (2024).","journal-title":"Cancers"},{"key":"2088_CR52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1042\/BST20253034","volume":"53","author":"AN Nanjaraj Urs","year":"2025","unstructured":"Nanjaraj Urs, A. N., Kim, L. & Zaher, H. S. Insights into the role of collided ribosomes during the activation of the integrated stress response. Biochem. Soc. Trans. 53, 615\u2013626 (2025).","journal-title":"Biochem. Soc. Trans."},{"key":"2088_CR53","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1261\/rna.027656.111","volume":"18","author":"R Weissbach","year":"2012","unstructured":"Weissbach, R. & Scadden, A. D. Tudor-SN and ADAR1 are components of cytoplasmic stress granules. RNA 18, 462\u2013471 (2012).","journal-title":"RNA"},{"key":"2088_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ni.1680","volume":"10","author":"JC Hartner","year":"2009","unstructured":"Hartner, J. C., Walkley, C. R., Lu, J. & Orkin, S. H. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 10, 109\u2013115 (2009).","journal-title":"Nat. Immunol."},{"key":"2088_CR55","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1016\/j.molcel.2023.09.018","volume":"83","author":"SB Hu","year":"2023","unstructured":"Hu, S. B. et al. ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation. Mol. Cell 83, 3869\u20133884.e3867 (2023).","journal-title":"Mol. Cell"},{"key":"2088_CR56","doi-asserted-by":"publisher","first-page":"956649","DOI":"10.3389\/fcell.2022.956649","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu, J., Wang, F., Zhang, Y., Liu, J. & Zhao, B. ADAR1-mediated RNA editing and its role in cancer. Front. Cell Dev. Biol. 10, 956649 (2022).","journal-title":"Front. Cell Dev. Biol"},{"key":"2088_CR57","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41594-026-01771-1","volume":"33","author":"T Inada","year":"2026","unstructured":"Inada, T. Ribosome-associated quality control and related mechanisms. Nat. Struct. Mol. Biol. 33, 394\u2013407 (2026).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2088_CR58","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2015.07.041","volume":"162","author":"DJ Young","year":"2015","unstructured":"Young, D. J., Guydosh, N. R., Zhang, F., Hinnebusch, A. G. & Green, R. Rli1\/ABCE1 recycles terminating ribosomes and controls translation reinitiation in 3\u2019UTRs in vivo. Cell 162, 872\u2013884 (2015).","journal-title":"Cell"},{"key":"2088_CR59","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1093\/nar\/gkl441","volume":"34","author":"N Shen","year":"2006","unstructured":"Shen, N., Guo, L., Yang, B., Jin, Y. & Ding, J. Structure of human tryptophanyl-tRNA synthetase in complex with tRNATrp reveals the molecular basis of tRNA recognition and specificity. Nucleic Acids Res. 34, 3246\u20133258 (2006).","journal-title":"Nucleic Acids Res."},{"key":"2088_CR60","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/nar\/gkm1153","volume":"36","author":"N Shen","year":"2008","unstructured":"Shen, N. et al. Catalytic mechanism of the tryptophan activation reaction revealed by crystal structures of human tryptophanyl-tRNA synthetase in different enzymatic states. Nucleic Acids Res. 36, 1288\u20131299 (2008).","journal-title":"Nucleic Acids Res."},{"key":"2088_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10133-z","volume":"10","author":"K Holzer","year":"2019","unstructured":"Holzer, K. et al. Nucleoporin Nup155 is part of the p53 network in liver cancer. Nat. Commun. 10, 2147 (2019).","journal-title":"Nat. Commun."},{"key":"2088_CR62","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"2088_CR63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014).","journal-title":"Science"},{"key":"2088_CR64","doi-asserted-by":"publisher","first-page":"pdb.prot090803","DOI":"10.1101\/pdb.prot090803","volume":"2016","author":"T Wang","year":"2016","unstructured":"Wang, T., Lander, E. S. & Sabatini, D. M. Single guide RNA library design and construction. Cold Spring Harb. Protoc. 2016, pdb.prot090803 (2016).","journal-title":"Cold Spring Harb. Protoc."},{"key":"2088_CR65","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/bioinformatics\/btv617","volume":"32","author":"J Winter","year":"2016","unstructured":"Winter, J. et al. caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR\/Cas9 screens. Bioinformatics 32, 632\u2013634 (2016).","journal-title":"Bioinformatics"},{"key":"2088_CR66","doi-asserted-by":"crossref","unstructured":"UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506\u2013D515 (2019).","DOI":"10.1093\/nar\/gky1049"},{"key":"2088_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14968-9","volume":"11","author":"C Chong","year":"2020","unstructured":"Chong, C. et al. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 11, 1293 (2020).","journal-title":"Nat. Commun."},{"key":"2088_CR68","doi-asserted-by":"publisher","first-page":"vbab041","DOI":"10.1093\/bioadv\/vbab041","volume":"2","author":"JP Quast","year":"2022","unstructured":"Quast, J. P., Schuster, D. & Picotti, P. protti: an R package for comprehensive data analysis of peptide- and protein-centric bottom-up proteomics data. Bioinform. Adv. 2, vbab041 (2022).","journal-title":"Bioinform. Adv."},{"key":"2088_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2088_CR70","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"2088_CR71","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013d552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02088-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:03:18Z","timestamp":1794315798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-02088-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1038\/s41556-026-02088-3","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}